Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Entamoeba histolytica | casein kinase II regulatory subunit family protein | 0.1616 | 0.5155 | 0.4586 |
Trichomonas vaginalis | casein kinase II beta chain, putative | 0.1616 | 0.5155 | 0.4586 |
Onchocerca volvulus | Casein kinase II subunit beta homolog | 0.1616 | 0.5155 | 0.5 |
Plasmodium falciparum | casein kinase 2, alpha subunit | 0.2966 | 1 | 1 |
Giardia lamblia | Kinase, CMGC CK2 | 0.2966 | 1 | 1 |
Trichomonas vaginalis | casein kinase II beta chain, putative | 0.1616 | 0.5155 | 0.4586 |
Trichomonas vaginalis | CMGC family protein kinase | 0.2966 | 1 | 1 |
Plasmodium vivax | casein kinase 2, alpha subunit, putative | 0.2966 | 1 | 1 |
Leishmania major | casein kinase II, putative | 0.2966 | 1 | 1 |
Trichomonas vaginalis | casein kinase II beta chain, putative | 0.1616 | 0.5155 | 0.4586 |
Trichomonas vaginalis | casein kinase II beta chain, putative | 0.1616 | 0.5155 | 0.4586 |
Trichomonas vaginalis | CMGC family protein kinase | 0.2966 | 1 | 1 |
Trypanosoma cruzi | casein kinase II, putative | 0.2966 | 1 | 1 |
Trichomonas vaginalis | casein kinase II beta chain, putative | 0.1616 | 0.5155 | 0.4586 |
Trichomonas vaginalis | casein kinase II beta chain, putative | 0.1616 | 0.5155 | 0.4586 |
Schistosoma mansoni | casein kinase II beta subunit | 0.1616 | 0.5155 | 0.5155 |
Echinococcus granulosus | casein kinase ii subunit beta | 0.1616 | 0.5155 | 0.5155 |
Entamoeba histolytica | casein kinase II regulatory subunit family protein | 0.1616 | 0.5155 | 0.4586 |
Mycobacterium tuberculosis | Probable NADH dehydrogenase I (chain H) NuoH (NADH-ubiquinone oxidoreductase chain H) | 0.0179 | 0 | 0.5 |
Entamoeba histolytica | protein kinase domain containing protein | 0.2966 | 1 | 1 |
Trichomonas vaginalis | casein kinase II beta chain, putative | 0.1616 | 0.5155 | 0.4586 |
Trichomonas vaginalis | casein kinase II beta chain, putative | 0.1616 | 0.5155 | 0.4586 |
Trichomonas vaginalis | casein kinase II beta chain, putative | 0.1616 | 0.5155 | 0.4586 |
Trichomonas vaginalis | casein kinase II beta chain, putative | 0.1616 | 0.5155 | 0.4586 |
Entamoeba histolytica | casein kinase, putative | 0.2966 | 1 | 1 |
Trichomonas vaginalis | CMGC family protein kinase | 0.2966 | 1 | 1 |
Loa Loa (eye worm) | CMGC/CK2 protein kinase | 0.2966 | 1 | 1 |
Echinococcus multilocularis | casein kinase ii subunit alpha | 0.2966 | 1 | 1 |
Trichomonas vaginalis | CMGC family protein kinase | 0.2966 | 1 | 1 |
Trichomonas vaginalis | casein kinase II beta chain, putative | 0.1616 | 0.5155 | 0.4586 |
Brugia malayi | Csnk2b protein | 0.1616 | 0.5155 | 0.4586 |
Trichomonas vaginalis | casein kinase II beta chain, putative | 0.1616 | 0.5155 | 0.4586 |
Echinococcus granulosus | casein kinase ii subunit alpha | 0.2966 | 1 | 1 |
Mycobacterium ulcerans | NADH dehydrogenase subunit H | 0.0179 | 0 | 0.5 |
Trichomonas vaginalis | casein kinase II beta chain, putative | 0.1616 | 0.5155 | 0.4586 |
Trichomonas vaginalis | CMGC family protein kinase | 0.2966 | 1 | 1 |
Plasmodium vivax | unspecified product | 0.2966 | 1 | 1 |
Wolbachia endosymbiont of Brugia malayi | NADH dehydrogenase subunit H | 0.0179 | 0 | 0.5 |
Trichomonas vaginalis | casein kinase II beta chain, putative | 0.1616 | 0.5155 | 0.4586 |
Loa Loa (eye worm) | Csnk2b protein | 0.1616 | 0.5155 | 0.4586 |
Trichomonas vaginalis | casein kinase II beta chain, putative | 0.1616 | 0.5155 | 0.4586 |
Toxoplasma gondii | CMGC kinase, CK2 family | 0.2966 | 1 | 1 |
Schistosoma mansoni | protein kinase | 0.2966 | 1 | 1 |
Trichomonas vaginalis | CMGC family protein kinase | 0.2966 | 1 | 1 |
Entamoeba histolytica | casein kinase II regulatory subunit family protein | 0.1616 | 0.5155 | 0.4586 |
Trypanosoma brucei | Casein kinase II | 0.2966 | 1 | 1 |
Onchocerca volvulus | Casein kinase II subunit beta homolog | 0.1616 | 0.5155 | 0.5 |
Giardia lamblia | Casein kinase II beta chain | 0.1616 | 0.5155 | 0.4586 |
Trichomonas vaginalis | CMGC family protein kinase | 0.2966 | 1 | 1 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.